UBS Group’s InMed Pharmaceuticals INM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.2K | Buy |
|
|||||
|
2025
Q1 | $12.6K | Sell |
|
|||||
|
2024
Q4 | $49.3K | Sell |
|
|||||
|
2024
Q3 | $50.3K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $15 | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $48 | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $2.83K | Buy |
|
|||||
|
2022
Q4 | $1.68K | Sell |
|
|||||
|
2022
Q3 | $38K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $9K | Buy |
|
|||||
|
2021
Q2 | $7K | Buy |
|
|||||
|
2021
Q1 | $3K | Buy |
|